AQLGX Fees and Costs — Alta Quality Growth Fund, Institutional Shares

Data updated: 2025-12-01

The net expense ratio is 0.79%: a 0.75% management fee plus 0.40% other expenses, less a 0.36% fee waiver. There are no sales loads or redemption fees. In fiscal 2024 the fund paid $5K in broker commissions, 0.0079% of average net assets, and portfolio turnover was 25%.

AQLGX Fees and Expenses

Annual operating expenses and sales charges of AQLGX. Prospectus, as of January 31, 2025.

Annual operating expenses
Management fee0.75%
12b-1 fee0.00%
Other expenses0.40%
Gross expense ratio1.15%
Fee waiver−0.36%
Net expense ratio0.79%
Sales charges
Max front load0.00%
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentYes

AQLGX Costs Over Time

On $10,000 invested in AQLGX, assuming 5% a year before costs, total costs come to $501 over 5 years, cutting the return by 0.84% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 0.79%)$83$259$451
Trading costs (broker commissions)$1$3$5
Lost growth on money paid in costs$0$13$46
Total costs$84$275$501
Value after costs$10,416$11,301$12,262
Impact on return, per year0.84%0.84%0.84%

AQLGX Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending September 30, 2024.

  • Explicit cost rate (commissions ÷ average net assets): 0.0079%
  • Total broker commissions: $5K
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 25%
  • Securities lending: none during the year

AQLGX Agency Brokers

Commissions paid.

BrokerAmountShare
Weeden Prime Services LLC$5K100.00%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.